HAVCR2 and ovarian cancer: This observation parallels results from a recent study on ovarian cancer, which demonstrated that PD-1+TIM-3+CD8+ TILs retained the proliferative potential but exhibited impaired functionality, leading to poor clinical outcomes 63.